Cyclic dinucleotides as anticancer agents
US10519187B2 · kind B2 · utility
0Cited by
0References
70Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 11, 2019 |
| Grant date | Dec 31, 2019 |
| Priority date | — |
| Expiry date | Feb 11, 2039 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K16/2896
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention is directed to compounds of the formulae I, II and III as shown below wherein all substituents are defined herein, as well as pharmaceutically acceptable compositions comprising compounds of the invention and methods of using said compositions in the treatment of various disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.